clotting

Medco to Include Genetics in Comparison of Anti-Clotting Drug Effectiveness

October 28, 2009
Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix ®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as...
Read More

More Evidence that Genetics Can Reduce the Efficacy of Anti-Clotting Medication Clopidogrel

August 26, 2009
A new report in the Journal of the American Medical Association adds to the mounting evidence that genetic variations impact the efficacy of clopidogrel (Plavix ®), a drug used to...
Read More

Surgeon General Issues Call to Action on VTE: 23andMe Assesses Genetic Risk for Customers

September 17, 2008
This Monday acting Surgeon General Steven K. Galson issued a Call to Action to reduce the number of people in the United States affected by two serious blood clotting conditions:...
Read More